These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20265748)

  • 1. Variations in prothrombin and antithrombin in patients with thrombosing tendencies.
    HURN M; BARKER NW; MANN FD
    Am J Clin Pathol; 1947 Sep; 17(9):709-11. PubMed ID: 20265748
    [No Abstract]   [Full Text] [Related]  

  • 2. Variations in prothrombin and antithrombin following the administration of dicumarol.
    HURN M; BARKER NW; MANN FD
    Am J Clin Pathol; 1947 Sep; 17(9):712-8. PubMed ID: 20265749
    [No Abstract]   [Full Text] [Related]  

  • 3. [The significance of prothrombin, antithrombin and fibrinogen for the shortening of the blood coagulation rate during surgery and anesthesia].
    WILLE P
    Zentralbl Gynakol; 1959 Jul; 81():1195-200. PubMed ID: 13844795
    [No Abstract]   [Full Text] [Related]  

  • 4. The determination of prothrombin (two-stage method) and antithrombin using commercially available reagents.
    HURN M; MANN FD
    Am J Clin Pathol; 1947 Sep; 17(9):741-6. PubMed ID: 20265754
    [No Abstract]   [Full Text] [Related]  

  • 5. An antithrombin reaction to prothrombin activation.
    Seegers WH; Johnson JF; Fell C
    Am J Physiol; 1954 Jan; 176(1):97-103. PubMed ID: 13124503
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of heparin on prothrombinic activity, on circulatory anticoagulants (antithromboplastin, plasma and serum antithrombin, antifibrinogen, on utilization of prothrombin, on conversion and acceleration factors in prothrombin conversion, on proteinemia, and on protein fraction].
    MARRAZZA P; DI GIROLAMO L
    Arch Sci Med (Torino); 1952 Jan; 93(1):9-16. PubMed ID: 14944438
    [No Abstract]   [Full Text] [Related]  

  • 7. NEUTRALIZATION OF AUTOPROTHROMBIN C ACTIVITY WITH ANTITHROMBIN.
    SEEGERS WH; COLE ER; HARMISON CR; MONKHOUSE FC
    Can J Biochem; 1964 Mar; 42():359-64. PubMed ID: 14164282
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies upon the relation between plasma antithrombin and heparin; influence of plasma antithrombin on prothrombin time.
    TANTURI CA; WETZEL NC
    Am J Med Sci; 1949 Apr; 217(4):410-20. PubMed ID: 18115156
    [No Abstract]   [Full Text] [Related]  

  • 9. [The antithrombin effect of the fibrinogen of some mammals].
    BURSTEIN M; GUINAND A
    Sang; 1954; 25(9):919-24. PubMed ID: 13225578
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in plasma prothrombin, Ac-globulin, and antithrombin concentration following intravenous administration of estrogens.
    JOHNSON JF
    Proc Soc Exp Biol Med; 1957 Jan; 94(1):92-4. PubMed ID: 13400879
    [No Abstract]   [Full Text] [Related]  

  • 11. THE INFLUENCE OF INORGANIC SALTS ON PLASMA ANTITHROMBIN ACTIVITY.
    MONKHOUSE FC
    Thromb Diath Haemorrh; 1963 Jul; 143():387-94. PubMed ID: 14081261
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombosis from a prothrombin mutation conveying antithrombin resistance.
    Miyawaki Y; Suzuki A; Fujita J; Maki A; Okuyama E; Murata M; Takagi A; Murate T; Kunishima S; Sakai M; Okamoto K; Matsushita T; Naoe T; Saito H; Kojima T
    N Engl J Med; 2012 Jun; 366(25):2390-6. PubMed ID: 22716977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DIFFERENTIATION OF THE INHIBITORS OF THE CONVERSION OF FIBRINOGEN INTO FIBRIN].
    VERMYLEN C; VERSTRAETE M
    Nouv Rev Fr Hematol; 1965; 5():376-82. PubMed ID: 14307711
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a new laboratory test to evaluate antithrombin resistance in plasma.
    Murata M; Takagi A; Suzuki A; Okuyama E; Takagi Y; Ando Y; Kato I; Nakamura Y; Murate T; Matsushita T; Saito H; Kojima T
    Thromb Res; 2014 Feb; 133(2):293-8. PubMed ID: 24325876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect.
    de la Morena-Barrio ME; Martínez-Martínez I; de Cos C; Wypasek E; Roldán V; Undas A; van Scherpenzeel M; Lefeber DJ; Toderici M; Sevivas T; España F; Jaeken J; Corral J; Vicente V
    J Thromb Haemost; 2016 Aug; 14(8):1549-60. PubMed ID: 27214821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
    EGEBERG O
    Thromb Diath Haemorrh; 1965 Jun; 13():516-30. PubMed ID: 14347873
    [No Abstract]   [Full Text] [Related]  

  • 17. THE KINETICS OF THROMBIN ACTIVITY IN RECALCIFIED BLOOD PLASMA.
    GRANNIS GF; KAZAL LA; TOCANTINS LM
    Thromb Diath Haemorrh; 1965 Jun; 13():361-72. PubMed ID: 14347860
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma antithrombin in thrombosis, hemorrhage, and liver disease.
    GRIFFITH WH
    J Lab Clin Med; 1952 Sep; 40(3):367-73. PubMed ID: 14955655
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tromexan: a new synthetic antithrombin].
    JENTZER A; CLERC R
    Presse Med (1893); 1950 Dec; 58(77):1365. PubMed ID: 14808005
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antithrombin resistance: a new mechanism of inherited thrombophilia].
    Kojima T; Takagi A; Murata M; Takagi Y
    Rinsho Ketsueki; 2015 Jun; 56(6):632-8. PubMed ID: 26256872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.